Two-Year Outcome of Treat-And-Extend Aflibercept After Ranibizumab in Age-Related Macular Degeneration and Polypoidal Choroidal Vasculopathy Patients
Clinical Ophthalmology - New Zealand
doi 10.2147/opth.s172115
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 1, 2018
Authors
Publisher
Informa UK Limited